- Accueil
- Recherche
- Axes de recherche
- Maladies infectieuses en transplantation
- Sélection de publications
Sélection de publications
Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: a systematic review and meta-analysis
Fernández-Ruiz M, Giménez E, Lora D, Aguado JM, Pascual M, Manuel O
Am J Transplant 2018 Oct 31
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M, Rettby N, Perreau M, Pascual M, Pantaleo G, Manuel O
Vaccine 2018 Sep 1
Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.
Aguado JM, Manuel O
Clin Microbiol Infect 2018 Jun
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients
Jaamei N, Koutsokera A, Pasquier J, Mombelli M, Meylan P, Pascual M, Aubert JD, Manuel O
Transpl Infect Dis 2018 Mar 30
Immune Monitoring for CMV in Transplantation.
Yong MK, Lewin SR, Manuel O
Curr Infect Dis Rep 2018 Mar 14
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
Stucchi RSB, Lopes MH, Kumar D, Manuel O
Transplantation 2018 Feb
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D, Kralidis G, Carrel T, Cusini A, Garzoni C, Hullin R, Meylan PR, Mohacsi P, Mueller NJ, Ruschitzka F, Tozzi P, van Delden C, Weisser M, Wilhelm MJ, Pascual M, Manuel O, Swiss Transplant Cohort Study (STCS).
BMC Infect Dis 2016 Jul 8
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D, Pascual M, Lartey S, Pathirana RD, Bredholt G, Hoschler K, Hullin R, Meylan P, Cox RJ, Manuel O
Vaccine 2016 Jun 30
Bloodstream infections after solid-organ transplantation.
Kritikos A, Manuel O
Virulence 2016 Apr 2
Impact of anti-T cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplants recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P. and Manuel O.
Transplantation 2012. In press
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O., Perrottet N. and Pascual M.
Expert Rev Anti Infect Ther. 2011 Nov;9(11):955-65
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.-A., Venetz J.-P., Calandra T. and Cavassini M.
Clin Infect Dis. 2011 Jan 15;52(2):248-56
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.-P., Nseir G., Meylan P.R. and Manuel O.
Transplantation. 2011 Jan 27;91(2):251-5
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.-P., Decosterd L.A., Buclin T., Meylan P.R.
Clin Transplant. 2010 Nov-Dec;24(6):794-800
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O., Asberg A., Pang X., Rollag H., Emery V.C., Preiksaitis J.K., Kumar D., Pescovitz M.D., Bignamini A.A., Hartmann A., Jardine A.G. and Humar A.
Clin Infect Dis. 2009 Oct 15;49(8):1160-6
An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O., Pang X.L., Humar A., Kumar D., Doucette K. and Preiksaitis JK.
J Infect Dis. 2009 Jun 1;199(11):1621-8
Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients.
Manuel O., Humar A., Chen M.H., Chernenko S., Singer L.G., Cobos I. and Kumar D.
Am J Transplant. 2007 Nov;7(11):2567-72
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.-P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R. and Pascual M.
Swiss Med Wkly. 2007 Dec 1;137(47-48):669-76
Contacts
CHUV
BH08/652
Rue du Bugnon 46
1011 Lausanne, Suisse
Centre de transplantation
d'organes
Rue du Bugnon 46
CH - 1011 Lausanne, Vaud, Suisse
+41 21 314 2403
Centre de transplantation
d'organes
Rue du Bugnon 46
CH - 1011 Lausanne, Vaud, Suisse
+41 21 314 2403